Bleichroeder Acquisition II
BBCQ · Nasdaq
NO ACTION REQUIRED
Nothing left to do
The purchase completed and the shares became shares in the company it bought. There is no deadline left to miss.
Cash at settlement
The last figure filed while this was still a SPAC.
Last close
Daily close
Trust settled
There is no line to draw here. This vehicle has finished: the cash was paid back or spent closing the deal, so the last filed figure describes an account that no longer exists and would be a floor under nothing.
SpacBrain’s read
Trust settled
The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
Change on the last daily close-5.7% day
$10.17 is the last cash-per-share figure filed while this was still a SPAC. That account has since been settled, so it is history rather than a floor under this price.
In plain terms
- What it is
- A $287.5M SPAC from Bleichroeder, listed on Nasdaq in January 2026. Each unit put $10.00 into the shareholders' cash account at listing; by the end it held $10.17 a share — interest earned on the account, plus any payments the sponsor made to extend the deadline, spread over the shares that never cashed out.
- What it's doing now
- It agreed in February 2026 to buy Pasqal, a neutral-atom quantum computing hardware and software company based in France. The deal valued that business at about $2.00B. That purchase completed, and it stopped being a SPAC — the shares became shares in the business it bought.
- What you should know
- This SPAC has finished. The purchase completed, and the shares became shares in the company it bought — anyone who wanted the cash instead asked for it at the vote, so there is no cash left here to claim and no deadline left to miss.
At a glance
- Where it stands
- Closed (deSPAC) · next dated event 31 December 2026
- Outside date — not a date on which you can claim cash.
- The business it bought
- Pasqal builds neutral-atom quantum processing units (QPUs) and sells them outright to national labs and HPC centers, plus QPU-related services (cloud computing time, maintenance, R&D) and cryostat hardware (France)
- Revenue $19M (FY2025) as reported.
- Industry
- Information Technology — neutral-atom quantum computing hardware and software
- Deal value
- $2.0B
- announced 28 February 2026
- Price vs cash at settlement
- $9.79 vs $10.17
- $0.38 below the last filed cash figure — the account has since been settled
- Cash in trust when it settled
- $292.3M
- the last trust total filed while this was still a SPAC — the account has since been paid out or used to close the deal
- IPO
- 8 January 2026
- $288M raised · 100.0% of each $10 unit into trust
- Headquarters
- 1345 AVENUE OF THE AMERICAS, NEW YORK, NY, 10105
- registered in the Cayman Islands
- Lead underwriter
- Cohen & Company Capital Markets
- Key officers
- Gundlach Andrew (Chief Executive Officer) · Combes Michel · Padula Marcello J. (Chief Operating Officer)
- Listed securities
- BBCQ common · BBCQ common $9.80 · BBCQU unit $10.09
As last filed, 30 June 2026. That was the account's last filed value before it was settled — the company does not hold it now.
source: 10-Q acc 0001213900-26-089101
- vs last filed NAV
- 3.7%below cash
- $10.17, 10-Q as of Jun 30, 2026, acc 0001213900-26-089101
Measured against the last filed cash figure. No accrued estimate is published for this SPAC, so no second reading is shown.
Nothing dated is on file. That is an absence in the record, not a statement that nothing is coming.
Yield to redemption
Nothing left to redeem — no yield to compute.
This SPAC has finished — its trust was paid back or used to close the deal, so there is nothing left to redeem and no yield to compute. A yield to redemption is a claim that you can hand these shares back for the trust cash. That account is closed, so this page will not print a number here.
What happened to the cash
The reasoning behind the verdict above, in the order the filings establish it.
- The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
- $10.17 a share is the last cash figure filed while this was still a SPAC. It is a record of what the account held, not money anyone can ask for now.
What has happened, and what is coming
5 dated milestonesEvery dated step from the day it listed to the next date you may have to act on. Where you have to do something, the day your broker needs the instruction is marked too.
- 28 February 2026Deal announcedpassed
Combination with Pasqal
On the Pasqal combination
Show the earlier 1 milestone
- 8 January 2026IPOpassed
$288M raised into trust
Presentations
archived in fullEvery investor deck this SPAC has filed, kept slide by slide, with the SEC original beside it.
Investor presentations · archived in full
The deal
terms as filedWhat it is buying, on what terms, and how much of the combined company new shares take from you.
- Pasqal$2.0B · announced 28 February 2026closedInformation Technologypost-close PSQLWeb research
What Pasqal does — read from pasqal.com on 14 August 2026
Pasqal is a quantum computing company developing neutral-atom quantum processors designed to scale toward industrial applications, integrated into HPC and cloud environments.
EnergyFinanceLogisticsHigh-Performance ComputingArtificial IntelligenceChemistry & Materials SimulationVote 25 August 2026 · tender by about 21 August 2026.
Pasqal Holding SAS is a French quantum computing company founded in 2019 as a spin-off from the Institut d'Optique Graduate School, co-founded by 2022 Nobel Prize Laureate Alain Aspect and Antoine Browaeys, a co-inventor of neutral-atom quantum computing and recipient of the 2025 John Stewart Bell Prize. Headquartered in Palaiseau, France, with offices in Saudi Arabia, Canada, the United States, and South Korea, Pasqal develops full-stack neutral-atom quantum computers encompassing hardware, software, and cloud delivery. The company has deployed seven quantum processing units to date with three more in production, claiming the largest installed base among pure-play neutral-atom quantum computing companies worldwide. Pasqal has demonstrated more than 1,000 trapped atoms and publicly targets 10,000-plus physical qubits per QPU and 200-plus logical qubits by the end of 2029, operating across both analog and fault-tolerant modes on the same hardware platform. The company employs over 275 people including 70 PhDs across more than 30 nationalities and holds 85 patents.
Pasqal serves over 25 commercial customers and partners spanning more than 35 customer engagements and 25-plus identified industrial use cases across energy, finance, logistics, and advanced manufacturing. Key customers include Saudi Aramco, CMA CGM, Sumitomo, Thales, LG Electronics, BMW Group, Capgemini, Crédit Agricole CIB, and OVHcloud, while strategic technology partnerships span IBM (Pasqal is part of the IBM Quantum Network), NVIDIA, Google Cloud, and Microsoft Azure. In May 2026, Pasqal and Aramco inaugurated Saudi Arabia's first quantum computer and the Middle East's first commercial Quantum Computing as a Service platform, a 200-programmable-qubit system deployed at Aramco's Dhahran data center. Pasqal researchers have also published in Nature, using analog quantum simulations to explain the properties of a real-life magnetic material containing rare earth elements, with some calculations already reaching what the company describes as a quantum advantage regime. The company reported approximately 100 percent revenue growth in 2025 (unaudited), roughly €16 million in commercial revenue, and approximately $80 million in booked and awarded business including grants.
Backed by more than $300 million in total private funding from investors including Quantonation, Bpifrance, the European Innovation Council Fund, Temasek, Wa'ed Ventures (Aramco's venture arm), and Eni Next, Pasqal announced on March 4, 2026 a definitive business combination agreement with Bleichroeder Acquisition Corp. II (Nasdaq: BBCQ), a SPAC led and backed by Michel Combes and Andrew Gundlach. The transaction values Pasqal at $2.0 billion pre-money, with a pro forma enterprise value of approximately $2.0 billion and a pro forma market capitalization of approximately $2.6 billion. The deal is expected to provide approximately $500 million in gross proceeds, assuming no shareholder redemptions and completion of the convertible financing, comprising roughly $289 million in Bleichroeder trust cash and $200 million in committed convertible financing. The convertible financing was subsequently upsized, with the Securities Purchase Agreement subscription price increasing by $50 million to $250 million, backing $312.5 million in senior unsecured convertible bonds and
Deal structureSEC-primary — BCA 8-K / S-4 / DEFM14A$2.0Bvs$2.6B+32% dilutionEffective equity counts every claim on the post-close company at $10.00 — rollover, public shares, the founder promote and the PIPE. The headline counts only the target.
- PIPE
- ≈ $200M · unsourced
- Min-cash condition
- $150M
- Sponsor promote
- 25%
- Break fee
- $3M
- Pro-forma shares
- 264.4M
- Exchange ratio
Pasqal shares are exchanged for New Pasqal Shares at an Exchange Ratio calculated by dividing the overall value of Pasqal by the overall value of the Parent Surviving Corporation, based on a deemed value of $10 per Parent Surviving Corporation Ordinary Share; each Bleichroeder Class A and Class B ordinary share converts 1:1.more ▾less ▴
PIPE structure:convertible bonds: $250,000,000 aggregate principal of senior unsecured convertible bonds purchased for $200,000,000 (20% original issue discount), plus Investment Warrants for 125% of the underlyingmore ▾less ▴
PIPE investors:Led by Inflection Point Asset Management / Inflection Point Fund I LP (sponsor-affiliated), with existing Pasqal anchor investor BPIfrance Large Venture and other new institutional investors.more ▾less ▴
PIPE terms — instrument, coupon, conversion price and any reset floor — are not sourced for this deal. The size above is itself unsourced — a stored figure no filing we hold states — so neither the size nor the terms should be read as cited.
Minimum cash: $150M from the trust together with other financing.Outside date: 31 December 2026 — the contractual long-stop for closing. It is not a redemption deadline and confers no right to cash.Lock-up:The Lock-Up Period shall terminate for Securityholders, upon the earlier of (x) 180 days after the Closing Date, (y) the day after the date on which the closing price of the Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Closing Date, and (z) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their shares for cash, securities or other propertymore ▾less ▴
What it is being valued atSEC-primary — the filed capitalisation tableThree different numbers are all called the deal value
They are not the same fact, and only the last one is what a valuation multiple may be struck on.
Pre-money equity value of the target$2,000MWhat Pasqal on its own is valued at, before a dollar of the SPAC's trust or the PIPE reaches it. This is the price agreed for the business itself.
Pro-forma equity value of the combined company$2,643.7Massumes 0% redemptions
Every share of the combined company, marked at the reference price, once the deal closes — the business PLUS the cash that arrives with it. This is the figure press headlines quote, and it is bigger than the business for that reason alone.
Cash on the balance sheet at close$645.2Massumes 0% redemptions
Money the transaction puts INTO the company. It is counted inside the equity value above, which is why it comes straight back out to reach the figure below — nobody pays a revenue multiple for a bank balance.
Pro-forma enterprise value$1,998.5MThe combined company net of that cash — what the buyers are paying for the BUSINESS. Every multiple below is struck on this figure and on nothing else.
What that price is, per dollar of sales
Enterprise value ÷ FY2025 revenue103×$1,998.5M ÷ $19.4M of FY2025 revenue. $1 of Pasqal's 2025 reported sales is being bought for $103.00.
Enterprise value ÷ EBITDA — not shown
No EBITDA figure for Pasqal appears in any filing we hold, so no EV/EBITDA multiple is shown. We have not inferred one from a margin assumption — a multiple built on an assumed margin measures the assumption, not the company.
What qualifies these figures
- The equity and cash figures above assume NOBODY REDEEMS — the filing's own assumption, and the most favourable one available to it. Public shareholders in this market frequently redeem most of a trust; at a higher rate both figures fall together and the enterprise value the multiples are struck on does not move.
- The announced headline of $2,000M and the filed pro-forma equity value of $2,643.7M are not the same number. Both are recorded as stated; we have not reconciled them for you.
All figures above are stated in EX-99.1 investor deck (425)0001213900-26-073692
"Pro Forma Valuation at Closing" table in the filed deck; $2,643.7M − $645.2M = $1,998.5M holds as printed. Pre-money is stated as "~$2.0 billion" in prose and as "$2,000.0 Pasqal Rollover Equity Value" in the Uses table on the same slide, so it is stored at 2000.0 from the table rather than from the approximation. SUPERSEDED FIGURES, kept on the record: the same table in 8-K 0001213900-26-061043 (2026-05-26) reads "Less: Cash (649.1) Pro Forma Enterprise Value $1,994.6" — the cash balance moved $649.1M → $645.2M between the two filings (the deck restates Pasqal's own cash from €124.7M at 30-Apr-2026 to €120.1M at 31-May-2026), carrying the EV from $1,994.6M to $1,998.5M. We publish the later filing. Redemption assumption, footnote (4): "Assuming no redemptions." Note the cash here is NOT all transaction cash: the Sources table counts "Pasqal Existing Cash(2) 139.8" alongside "SPAC Cash in Trust(1,4) 291.4" and "Convertible Financing(3) 250.0".
The score
deterministic, from filed fieldsBBCQ is not in the scored universe, so no score is shown. A withheld score is a fact about the record, not a verdict about the company.
The score is only published for names that carry both a price and a filed cash-per-share figure — 292 of the tracked fleet today. The rest keep an empty dial rather than a modelled one, and fill in by themselves as the fields land.
The company
from SEC filingsRead the full profile
Bleichroeder Acquisition Corp. II is a $287.5 million Nasdaq SPAC. The company, headquartered at 1345 Avenue of the Americas in New York, NY, intends to focus its efforts on North American and European businesses in disruptive growth sectors—areas its management team believes are being transformed through technology adoption and where its operational and investment expertise provide a competitive advantage. The company's sponsor is Bleichroeder Sponsor 2 LLC, and its Chief Executive Officer is Andrew Gundlach. The company has announced a merger agreement with Pasqal, the French quantum-computing company, in a deal recorded at $2.0 billion, with a shareholder vote scheduled for 25 August 2026.
The company's initial public offering raised $250 million through the sale of 25,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share and one-third of one redeemable warrant. Whole warrants entitle holders to purchase one Class A ordinary share at $11.50 per share, exercisable 30 days after completion of the initial business combination and expiring five years thereafter. The units trade on Nasdaq under the symbol BBCQU, with the Class A ordinary shares and warrants trading separately under BBCQ and BBCQW, respectively. Underwriters Cohen Company Capital Markets, a division of Cohen Company Securities, LLC, hold a 45-day over-allotment option for up to 3,750,000 additional units. Of the IPO proceeds, $250 million ($287.5 million if the over-allotment is exercised in full) was placed in a U.S.-based trust account with Continental Stock Transfer Trust Company, representing $10.00 per unit.
In a concurrent private placement, the sponsor and the underwriters purchased an aggregate of 7,750,000 private placement warrants at $1.00 each ($7.75 million) — 5,000,000 to Bleichroeder Sponsor 2 LLC and 2,750,000 to the underwriters.
Material findings
from the full read of every filingEvery document this company files gets read whole — body and exhibits. These are the ones the read flagged as material, newest first, each citing its filing.
This exhibit clarifies the mechanical and financial backdrop for the announced Pasqal Holding SAS merger ahead of the January 9, 2028 deadline. By isolating advisor compensation away from the trust account—valued at $10.17 per share—the filing assures investors that sponsor-linked payouts will not erode redemption values. Conversely, the structure reveals significant contingent liabilities: failure to close due to company termination without cause accelerates six additional months of monthly fees alongside the full $1,850,000 or $600,000 waterfall, demonstrating rigid financial incentives tied to deal execution. Furthermore, the document details clauses assigning all intellectual property created during the search to the company and enforcing strict confidentiality, underscoring standard shell-company transition protocols. Tracking the deal calendar, the explicit reference to a Merger Agreement executed on February 28, 2026 signals that substantive negotiations preceded this administrative compensation adjustment, providing concrete validation of merger progress for shareholders evaluating their redemption rights.
SPAC investors face a compressed decision window between material receipt and the August 25 vote, directly impacting redemption behavior and post-deal liquidity. The jointly issued press release attributes to management that Pasqal leverages Nobel Prize-winning research to build neutral-atom quantum computing systems and cloud-ready software targeting optimization, simulation, and artificial intelligence. The companies state Pasqal employs approximately 300 people in France and serves over 25 clients and partners, listing Saudi Aramco, LG Electronics, Crédit Agricole CIB, CMA CGM, OVHcloud, Thales, IBM, and Sumitomo. The filing discloses Pasqal has secured more than USD 300 million in total funding from leading international investors and aims to list on Nasdaq through this transaction. Cautionary statements warn Pasqal confronts risks related to commercializing emerging quantum technology, dependence on senior management, potential needs for additional future financing, and heavy concentration of revenue in government or state-funded contracts.
Investors weighing redemption decisions must evaluate the target alongside the extensive forward-looking risk disclosures attached to the proxy. According to the joint press release and accompanying prospectus, Pasqal is a France-based neutral-atom quantum computing firm founded in 2019 that employs approximately 300 people and serves over 25 clients and partners, including Saudi Aramco, LG Electronics, Crédit Agricole CIB, CMA CGM, OVHcloud, Thales, IBM, and Sumitomo. The company leverages Nobel Prize-winning research to build high-performance quantum systems and cloud-ready software for optimization, simulation, and artificial intelligence, and has been backed by more than USD 300 million in total funding from leading international investors. Management and the target explicitly flag risks inherent to the venture, citing potential technical challenges, delayed commercialization or market acceptance for the emerging technology, reliance on strategic partners and third parties, concentration of revenue in contracts with government or state-funded entities, and a potential need for additional future financing prior to or after the Business Combination.
For investors tracking this deal, this supplement provides the final legal merger documents for the reincorporation step, confirming the 1:1 share exchange and the key deadline (effective date 27 August 2026, with automatic lapse on 31 October 2026). The trust account is disclosed at $289.7M. Redemption risk remains live, and any redemptions will reduce the post-merger cash available to the combined company. The corrected articles of association for the ultimate surviving company (Pasqal Holding) are now on the record. No new financial projections or business updates on Pasqal are provided.
According to the Supplement, the explicit linkage between redemption exercises, share count adjustments, and contributed asset valuation means actual trust distributions will mechanically scale post-combination ownership and net asset backing per share. The hard calendar deadlines eliminate indefinite extension ambiguity and force accelerated execution before the 31 October 2026 cutoff. The fixed one-to-one parity, combined with the accounting rule that contributions transfer at book value rather than fair market value under French General Chart of Accounts regulations, dictates how historical SPAC liquidity converts into the surviving entity’s equity base. As outlined in Section D of the Merger Agreement, the transaction targets market expansion, access to U.S. capital markets for institutional and retail investors, enhanced international credibility, and capital structure optimization to issue new financial instruments and employee incentive mechanisms. Under Article 3 of the New Pasqal Articles of Association, the surviving company’s corporate purpose centers on quantum computing, quantum simulation, neutral atom laser technologies, software/hardware development, IP exploitation, and consulting services. The appointed nine-member leadership and specified corporate governance rules in Articles 13 through 25 establish the operational and fiduciary framework for the listed European entity.
This filing provides the first detailed look at trust mechanics and deal economics for BBCQ since its IPO. Key for investors: (1) the trust is accumulating interest and the redemption value is already $10.17, (2) the Pasqal deal has a minimum cash condition of $150 million available at closing, (3) a $250 million convertible note PIPE (20% OID) is contingent on closing, and (4) there is a clear path to a year-end 2026 termination/long-stop with an automatic extension to 2027. The sponsor conduct: sponsor received 9.58 million founder shares for $25,000 (approx. $0.003/share) and agreed to not redeem in favor of the deal. The independent directors/COO/CFO received stock grants contingent on deal close. The company has substantial doubt about going concern absent a deal.
Show 24 more material filings
SEC effectiveness completes the regulatory prerequisite for distributing the definitive proxy and prospectus, locking in the August 25, 2026 shareholder vote and advancing the transaction timeline. Execution risk remains active, as the filing warns that 'the number of redemption requests made by Bleichroeder’s shareholders in connection with the Business Combination' could 'leave the combined company with insufficient cash to execute its business plans.' Regarding other substance, the jointly distributed press release attributes to Pasqal the following: it was founded by quantum physicists including Nobel Prize laureate Alain Aspect; launched its first commercial deployment in 2022; employs approximately 300 people; serves over 25 clients and partners; and has raised more than USD 300 million in total funding. Named commercial engagements and partnerships include Los Alamos National Laboratory, CINECA (which integrated a 140-qubit system with the Leonardo supercomputer), MegazoneCloud, Crédit Agricole CIB, Saudi Aramco, True Nexus, LG Electronics, CMA CGM, OVHcloud, Thales, IBM (noting Pasqal is part of the IBM Quantum Network), and Sumitomo. The filing states Pasqal's current systems exceed 1,000 physical qubits, with a long-term pathway toward more than 10,000 physical qubits and 200 logical qubits. The security register lists Class A ordinary shares, units each containing one Class A share and one-third of a warrant, and whole warrants exercisable for one Class A ordinary share at an exercise price of $11.50 per share.
This filing activates the redemption mechanics and sets the deadline for investors to either redeem at trust value or remain as shareholders in the combined quantum computing company. It provides the definitive terms for the business combination, including valuation, financing, governance, and the deadline for the transaction. Investors must act by August 21, 2026 to redeem.
Investors can now model redemption impacts against the $10.17 trust floor ahead of the August 25, 2026 vote. The registration statement effectiveness closes the regulatory review window, locks the merger schedule, and confirms the post-combination corporate name as Pasqal Holding SA with a projected Nasdaq ticker of PSQL and a dual-listing target on Euronext N.V. Paris. Per the press release issued by Pasqal and Bleichroeder, the target reports approximately 300 employees, over 25 clients and partners, and more than USD 300 million in total funding from leading international investors. The same press release asserts that Pasqal’s neutral-atom systems exceed 1,000 physical qubits, outlines a roadmap toward more than 10,000 physical qubits and 200 logical qubits, and cites commercial deployments and partnerships attributed to Los Alamos National Laboratory, CINECA, MegazoneCloud, Crédit Agricole CIB, Saudi Aramco, True Nexus, IBM (noted as part of the IBM Quantum Network), LG Electronics, CMA CGM, OVHcloud, Thales, and Sumitomo. All operational, technological, and partnership assertions originate from the co-authored press release.
Sets a hard vote date of August 25, 2026 for the Pasqal quantum-computing deal and confirms the deal survived three amendments in five months. The reincorporation into a French societe anonyme rather than a Delaware or Cayman entity is unusual for a deSPAC and changes the governance and shareholder-rights regime for holders who do not redeem.
The Exchange Ratio is 22.74: a stated pre-transaction equity valuation of Legacy Pasqal of $2,000,000,000 divided by 8,796,556 non-fully-diluted shares, over $10.00 per Bleichroeder Surviving Corporation share. A court-appointed commissaire a la fusion must verify it, so the filing says the ratio is subject to change. Closing requires New Pasqal to have access to no less than $150,000,000 before transaction expenses, from trust after redemptions plus the March 2026 Financing, expressly excluding the Series C raise closed February 27, 2026. The Sponsor directly owns 9,583,333 Founder Shares.
This amendment materially adjusts the post-business combination ownership structure by capping the equity incentive pool at 10% of redeemed-share-adjusted outstanding stock, directly informing prospective redemption yield calculations and management retention alignment. Forward-looking statements prepared by Bleichroeder and Pasqal’s management attribute specific operational and financial characteristics to the combined entity, including that shareholder redemptions could leave insufficient cash to execute business plans, that Pasqal concentrates revenue in contracts with government or state-funded entities, and that the company faces technical challenges and market acceptance risks while commercializing emerging artificial intelligence and machine learning technologies. The filing also registers securities with a par value of $0.0001 per Class A ordinary share and establishes a whole warrant exercise price of $11.50. These disclosures provide investors with documented parameters for evaluating dilution mechanics, liquidity preservation scenarios, and target execution risk prior to the definitive proxy distribution and final redemption tally.
Beyond structural changes, the filing details substantive risk profiles attributed to the target’s disclosures: Pasqal concentrates revenue in government or state-funded contracts, faces technical and commercialization challenges with emerging technology, navigates AI/machine learning adoption and regulatory landscapes, manages cybersecurity/data protection risks, and pursues dual listing ambitions on a U.S. exchange and Euronext N.V. Paris. The company maintains a limited operating history and depends on senior management retention. Personnel signatories include Wasiq Bokhari (President, Pasqal Holding SAS), Michel Combes (President, Parent Merger Sub), and Marcello Padula (Chief Executive Officer, Parent). The amendment matters because it locks in a clear dilution ceiling for redeeming shareholders, introduces conditional compensation metrics that will require final board ratification, and underscores execution dependencies on foreign equity law and successful proxy solicitation.
Read against Amendment No. 3, the governing economics did not move: the same 22.74 Exchange Ratio, the same $2,000,000,000 Legacy Pasqal pre-transaction equity valuation over 8,796,556 non-fully-diluted shares, the same $150,000,000 minimum-cash access condition excluding the Series C raise closed February 27, 2026, and the same 9,583,333 Founder Shares held directly by the Sponsor. In both versions the illustrative per-share Redemption Price is still an unfilled bracket, so a holder cannot yet read the cash figure the redemption decision turns on.
Beyond transaction mechanics, the attached presentation advances Pasqal’s commercial and technical thesis through attributions by presenters Wasiq Bokhari, Loïc Henriet, and Stéphane Rougeot. Management reports 16.5M in audited 2025 commercial revenue and 66M+ in booked and awarded business (including grants) as of March 2026, backed by 10 commercial QPUs (seven installed, three in production). Executives assert delivery of 1,000+ physical qubits on a single neutral-atom machine consuming less than 4kW of power and operating without deep cryogenics. Named enterprise customers and channel partners include Aramco, Crédit Agricole, LG Electronics, IBM (IBM Quantum Network), NVIDIA (NVQLink), Microsoft Azure, Google Cloud, Capgemini, BCG, and Tata. Management projects a $720B cross-sector quantum market opportunity by 2040 per Global Quantum Intelligence data from February 2026. Technical claims cited include demonstrated quantum advantage in simulating the TmMgGaO4 rare-earth magnet, experimental implementation of a [[4,2,2]] error-detection code, and a roadmap targeting 200+ logical qubits with 99.9999% logical fidelity by 2029. Both companies highlight risks around shareholder redemptions concentrating public float, French sovereign oversight via BPI board representation, dependency on founding-team retention, and execution uncertainty on fault-tolerant scaling. Pro-forma capitalization assumes existing Pasqal shareholders at 76%, Bleichroeder shareholders at 11%, convertible investors at 10%, and the Bleichroeder sponsor at 3%.
For investors monitoring the redemption window, the explicit “assuming no redemptions” liquidity model signals that the transaction’s operational runway and growth execution hinge entirely on shareholder retention; any meaningful redemption rate would directly erode the $645.2 million cash target, forcing accelerated drawdowns on the $250 million convertible debt facility or triggering dilutive equity raises to sustain R&D through 2029. Beyond mechanics, Pasqal management asserts €16.5 million in audited 2025 commercial revenue against €3.5 million in 2024, with €66 million or more in booked and awarded business (including public grants) as of March 2026. Target enterprise and research clients cited in the presentation include Aramco, Credit Agricole, LG Electronics, Sumitomo, and CMA CGM, with channel distribution routed through Microsoft Azure, Google Cloud, and direct HPC/on-premise deployments. Industry research attributed to Global Quantum Intelligence (dated February 2026) projects a $720 billion quantum computing market by 2040. Technologically, management claims operation of seven commercial neutral-atom Quantum Processing Units (QPUs) plus three in production, highlighting a defect-free 1,024-atom register achievement and a demonstrated quantum advantage in TmMgGaO4 rare-earth magnetic material simulation in Q1 2026. Roadmap projections anticipate scaling to 10,000+ physical qubits and 200+ logical qubits with 99.9999% fidelity by 2029, supported by a stated manufacturing throughput target of up to 13 QPUs annually. The venture’s co-founders include Nobel laureate Prof. Alain Aspect and 2025 John S. Bell Prize winner Prof. Antoine Browaeys. Governance disclosures warn that French sovereign involvement via BPI and mandated prior authorization from the French Ministry of the Economy for quantum-tech acquisitions could introduce regulatory delays or board-level oversight. While none of these commercial or technological assertions alter the redemption countdown itself, they materially define whether public shareholders perceive sufficient post-deal capital adequacy, technical milestone probability, and sovereign-backed execution viability to justify foregoing the trust distribution.
While the established $10.17 trust share value and January 9, 2028 redemption deadline remain untouched, this amendment materially adjusts the economic and control landscape ahead of shareholder voting. Removing the additional one percent (1%) executive carve-out caps total dilution from the equity incentive plan at exactly ten percent (10%), which slightly improves the net asset backing per remaining public share compared to the original draft. Codifying board seats for Bpifrance Investissement and the EIC Fund formally embeds European state-backed and venture capital influence into the merged entity’s leadership, addressing minority governance expectations. These structural refinements lower founder/executive overhang concerns, streamline closing procedures, and signal progressing deal finalization, making it substantive for investors evaluating whether to redeem, hold, or vote through the proxy process.
The Exchange Ratio here is 23.04 — not the 22.74 stated in Amendment No. 2 (July 23, 2026) and Amendment No. 3 (July 31, 2026). The $2,000,000,000 Legacy Pasqal Pre-Transaction Equity Valuation and the $10.00 Bleichroeder Surviving Corporation share value are identical across all three; what moved is the denominator, from 8,678,789 Legacy Pasqal shares outstanding on a non-fully-diluted basis in this version to 8,796,556 in the later two. The $150,000,000 minimum-cash access condition and the Sponsor's 9,583,333 Founder Shares are unchanged.
These revisions alter post-merger board composition and executive equity terms, which impacts post-combination voting control and potential shareholder dilution, though they do not modify the $10.17 trust value per share, the $11.50 warrant exercise price, or the January 9, 2028 redemption deadline. The removal of the supplemental 1% executive grant reduces maximum executive overhang relative to earlier draft terms, while the codified designation rights for Bpifrance Investissement and the EIC Fund clarifies how major French institutional backers will influence board independence. The filing confirms the parties have progressed the business combination toward the definitive proxy stage by amending the merger agreement and noting the joint Form F-4 registration statement, yet it provides no new information regarding sponsor conduct, trust disbursements, or extension triggers. Investors tracking the transaction should monitor the upcoming definitive proxy statement/prospectus for concrete conversion ratios, special meeting dates, and final redemption windows.
Mechanically, the $649.1 million cash target is explicitly predicated on zero redemptions; if public shareholders redeem against the $10.17 trust value referenced in your tracking parameters, the post-combination capital base shrinks, which Pasqal’s risk factors warn could impair execution of its growth strategy or necessitate alternative financing before achieving the 10,000+ physical qubit and 200+ logical qubit targets management forecasts for 2029. Regarding non-mechanical substance, Pasqal’s management states it operates 7 quantum processing units in commercial use with 3 in production inside standard data centers consuming 4 kW of power, cites €16.5 million in 2025 commercial revenue and €66M+ of booked or awarded business as of March 2026, and lists customers including Aramco, Credit Agricole, LG Electronics, and CMA-CGM. Pasqal’s press release and investor materials attribute technical positioning to co-founders including 2022 Nobel Laureate Alain Aspect and 2025 John S. Bell Prize winner Antoine Browaeys, cite employment of over 275 personnel with more than 70 PhDs, and reference strategic integrations with NVIDIA’s CUDA-Q runtime, Microsoft Azure, and Google Cloud. A market size claim sourced to Global Quantum Intelligence (GQI) as of February 2026 estimates a $720B addressable opportunity by 2040 segmented across energy, advanced materials, life sciences, logistics, and financial services. The filing also flags French foreign investment regulations overseen by the Ministry of Economy and French state representation via BPI on the combined company board as operational dependencies.
Public filing of the Form F-4 initiates the definitive proxy distribution and shareholder voting timeline, making the record date and subsequent redemption window critical upcoming dates for capital preservation decisions. The $50.0 million PIPE expansion increases committed private capital and partially offsets liquidity shortfall risk should a portion of the $10.17 trust-value shares be redeemed before the 2028-01-09 deadline, though management’s own risk disclosures warn that heavy redemptions would concentrate ownership and restrict post-combination operational funding. Investors tracking sponsor conduct will note the internal reassignment of merger sub duties and updated recapitalization structure, while those modeling enterprise value must weight the stated $2.0 billion pre-money valuation against unverified technology milestones, commercial revenue scaling assumptions, and strategic partnership dependencies disclosed in the presentation.
This is the first point on an exchange ratio that then moved twice. Here it is 24.01, from the same $2,000,000,000 Legacy Pasqal Pre-Transaction Equity Valuation and $10.00 Bleichroeder Surviving Corporation share value used in every later version, divided by 8,330,989 Legacy Pasqal shares outstanding on a non-fully-diluted basis. Amendment No. 1 (June 25, 2026) restates it at 23.04 on 8,678,789 shares, and Amendments No. 2 and No. 3 at 22.74 on 8,796,556 shares. Any per-share figure read from this version is superseded.
This Rule 425 communication functions as a permitted pre-proxy technical update intended to shape the investment thesis before the shareholder vote. The document attributes the following substantive claims to Pasqal and its leadership: Chief Technology Officer Loïc Henriet reports that logical qubits outperformed physical qubits by more than 50% on average across 1,000 differential equations, delivering a factor of 10 improvement on a representative nonlinear problem, with median residuals of 0.042 versus 0.069 and errors of 0.011 versus 0.122. The filing asserts Pasqal operates at a combined gate fidelity of 99.4%, utilizes a [[4,2,2]] quantum error-detecting code that encodes 2 logical qubits into 4 physical qubits, employs over 275 people, and serves over 25 clients and partners including Aramco, CMA CGM, OVHcloud, Thales, IBM (noting participation in the IBM Quantum Network), and Sumitomo. Pasqal discloses more than USD 300 million in total funding, identifies the PROQCIMA/France 2030 programme as the research backer, and outlines a strategy focused on scaling hybrid quantum-classical workflows, improving gate performance, expanding logical qubit capacity, and advancing fault-tolerant architectures across aerospace, energy, pharmaceutical, finance, and materials sectors. Redemption trackers can use these validated technical milestones and disclosed partnership footprints to model enterprise value and assess redemption probability ahead of the F-4 proxy distribution, even though the cash mechanics and statutory deadlines remain unchanged.
The filing substantively advances the commercial narrative surrounding the merger target. According to the jointly issued press release, Pasqal and Aramco 'today officially inaugurated the Kingdom of Saudi Arabia’s first quantum computer' and unveiled 'the first commercial Quantum Computing as a Service (QCaaS) platform in the Middle East.' Pasqal’s Quantum Processing Unit, powered by neutral-atom technology and controlling 200 programmable qubits, was 'first deployed in November 2025' and now operates at Aramco’s data center in Dhahran. Aramco serves as a foundational customer progressing a roadmap of use cases spanning port logistics optimization, CO₂ storage optimization, well placement, and rig scheduling. Regarding corporate scale and capitalization, the document states Pasqal has been building hardware and software 'since 2019,' currently 'employs over 275 people,' and 'serves over 25 clients and partners,' including CMA CGM, OVHcloud, Thales, IBM, and Sumitomo. Pasqal holds 'more than USD 500 million in total funding from leading international investors,' while Aramco’s venture arm, Wa’ed Ventures, 'initially invested in Pasqal in January 2023.' Pasqal CEO Wasiq Bokhari describes the company’s core mission as enabling 'practical and secure quantum computing at scale today' through cloud-accessible platforms addressing complex industrial challenges. Forward-looking disclaimers warn that technical hurdles, regulatory shifts, or failure to realize anticipated merger benefits could materially alter outcomes. Because this communication introduces binding prospectus delivery language, operational milestones with a sovereign energy client, and precise headcount/funding metrics directly relevant to valuation diligence, it qualifies as material pre-vote intelligence for redemption decision-making.
Trust value per share is $10.08, slightly above the $10.00 IPO price. The completion window is 24 months from IPO (January 2028). The merger agreement has an outside date of December 31, 2026, with automatic extension to December 31, 2027. The deal includes a $200 million PIPE and a $2.0 billion valuation. The sponsor has agreed to vote in favor and not redeem. The company's working capital deficit and going concern disclosure suggest potential need for additional loans or working capital. The filing provides the first detailed financials since IPO and the merger agreement terms.
This filing does not amend the January 9, 2028 liquidation deadline, the $10.17 per-share trust account balance referenced in the registrant’s public filings, or the DEAL_ANNOUNCED business combination status. However, executive turnover in a pre-combination blank check company directly signals sponsor conduct and operational continuity. Shifting Andrew Gundlach from dual President/CEO responsibilities to Executive Chairman, while promoting Marcello Padula to Chief Executive Officer, represents an internal governance realignment that will dictate who leads merger negotiations, investor communications, and extension discussions. Because the Board confirmed no altered pay structures or undisclosed side agreements, the economic incentives driving the new leadership remain transparent. Investors tracking redemption windows, trust preservation, and sponsor diligence should monitor upcoming reports for strategic pivots, proxy solicitations, or amendment filings tied to this updated command hierarchy before the deadline expires.
For investors tracking redemption windows, trust distribution, and execution milestones, this communication delivers zero procedural updates to the existing calendar or capital structure. Instead, it serves as a Rule 425 messaging vehicle aimed at legitimizing listing timing and preemptively addressing liquidity concerns ahead of the shareholder vote. By formally documenting management's awareness that redemptions could starve the post-combination balance sheet, the filing places the burden of capital preservation squarely on anticipated vote outcomes and PIPE/convertible financing execution. The cited executive perspective and third-party analyst commentary are unverified promotional assertions, not historical disclosures, meaning they carry no contractual force over deal economics or sponsor obligations. Investors should monitor actual redemption submissions against the explicitly flagged cash-depletion risk and verify whether the anticipated dual-listing pathway aligns with exchange requirements once the registration statement declaration date arrives.
The document functions as an active retention tool to deter redemptions by highlighting sector momentum and attaching a $2 billion expected valuation to Pasqal (table footnoted 'As of April 23, 2026', 'Source: The companies'). Antoine Legault, VP of equity research at Wedbush Securities, attributes current market conditions to strong demand, claiming 'If you have quantum in your company name, you’re worth at least $1 billion from the get go' and estimating a game-changing quantum computer 'could be worth tens of billions in addressable market'. Christian Weedbrook, founder and CEO of Xanadu, characterizes the SPAC route as necessary for speed and capital raising, stating 'Time is of the essence,' 'It is a bit of a race.' Matt Kinsella, CEO of Infleqtion, echoed this urgency, saying he wanted to ensure the company raised needed capital before the window closed. John McPeake, senior research analyst at Rosenblatt Securities, cites renewed U.S. government interest and Nvidia’s recent launch of open source quantum AI models as legitimizing catalysts, projecting that industry road maps target 'fault tolerance' by 'the end of the decade'. Joe Fitzsimons, founder and CEO of Horizon Quantum, compares the timing to the AI boom, advising investors to enter 'just before ChatGPT comes out'. Pasqal CEO Wasiq Bokhari explicitly aligns the company’s strategy with this sentiment, stating 'People are realizing that quantum computing is only a few years behind AI' and confirming the goal to 'go out and tell our story'. The included comparative table lists employee counts and latest valuations/market caps for public veterans (Quantum Computing Inc. at $2.2 billion with 188 employees; IonQ at $17.3 billion with 1,132 employees; D-Wave at $7.9 billion with 395 employees; Rigetti at $6.1 billion with 164 employees), newly public firms (Infleqtion at $3.2 billion listed February 2026 with 250 employees; Xanadu at $8.3 billion listed March 2026 with 264 employees; Horizon Quantum at $616 million listed March 2026 with 50+ employees), and pipeline targets including Pasqal (297 employees, expected in second half of 2026), IQM (300+ employees, expected in second half of 2026), Terra Quantum (200 employees, expected sometime in 2026), Seeqc (42 employees, expected mid 2026), and Quantinuum (700 employees, TBD). Management’s Forward-Looking Statements section also warns of additional mechanics-related pressures: failure to secure shareholder or regulatory approval, disruption to Pasqal’s operations, concentration of revenue in government/state-funded contracts, and dependence on strategic partners.
This filing acts as pre-combination investor relations material, validating target-scale commercial activity ahead of the proxy vote. Wasiq Bokhari, CEO of Pasqal, stated the company delivered logical qubit demonstrations in 2025, is scaling towards 1000 qubits, and mapping a clear path toward fault-tolerant quantum computing. Pierre Dulon, Global Head of the Technology Sector at Crédit Agricole CIB, shared that partnering with Pasqal showed immediate relevance for concrete financial use cases, specifically credit-risk monitoring and portfolio optimization. According to the filing's company overview, Pasqal, headquartered in France, employs over 275 people, serves over 25 clients (listing CMA CGM, OVHcloud, Thales, IBM, and Sumitomo), and has received more than USD 300 million in total funding from international investors. System integration claims are attributed to European HPC centers GENCI and CINECA, who detailed embedding Pasqal neutral-atom processors into classical workflows through the HPCQS hybrid project co-funded by the European HPC Joint Undertaking and Italy’s Ministry of University and Research. Paco Martin of IBM outlined development on the Quantum Resource Management Interface (QRMI) for orchestrating quantum resources alongside classical clusters and AI accelerators in SLURM environments, while NVIDIA participated in sessions exploring hybrid quantum-classical architectures. Cross-border collaboration points were emphasized by P33 Chicago, Los Alamos National Laboratory, Institut quantique at Université de Sherbrooke, and PINQ². The document concludes with Rule 425 forward-looking statement disclaimers and transaction risk factors, directing security holders to consult the final Registration Statement and referencing earlier SEC documents filed on January 8, 2026, and January 9, 2026.
The filing advances the deal toward definitive voting materials without changing commercial terms, but supplies disclosure context that affects redemption strategy and post-merger capital sustainability. Management attribution: Pasqal CEO Wasiq Bokhari stated the SPAC merger and public listing constitute 'the first step toward becoming truly global' and emphasized that 'U.S. markets are the premier markets' for 'access to capital' and 'capital depth.' Sector benchmarking per Barron’s: three quantum firms completed SPAC mergers in 2026; Xanadu Quantum Technologies surged 15% on debut; IonQ surpassed $100 million in annual GAAP revenue in 2025; IQM plans to merge with Real Asset Acquisition next quarter. Academic/analyst commentary: University of Florida finance professor Jay Ritter told Barron’s that roughly 20 SPACs form monthly, historical de-SPAC equity returns have averaged a 60% decline in the 12 months post-merger, yet high redemption rates typically shield public investors from downside. Risk matrix per the disclaimer: Pasqal faces a limited operating history, concentration of revenue in government or state-funded contracts, significant technical commercialization hurdles, dependence on senior management retention, and objectives for dual listing on Euronext N.V. Paris alongside U.S. exchange maintenance. For redemption-track investors, these disclosures confirm the combination’s reliance on sustained public-market capital depth, flag the liquidity risk if redeemations outpace the $10.17 trust reserve plus PIPE commitments, and underscore that deal sequencing toward the Form F-4/mail-out date keeps the January 9, 2028 deadline active while subjecting the trust pool to standard redemption drawdown mechanics.
Showing the 30 most recent of 45 filings flagged material — the full feed is in Filings below.
Filings
live EDGAR feedEverything this company has filed with the SEC recently, newest first, each with a plain summary of what changed and why it matters.
What changed: Bleichroeder Acquisition Corp. II consummated its business combination with Pasqal Holding SAS on August 27, 2026. The SPAC merged into a surviving corporation that changed its name to Pasqal Holding SA (New Pasqal). Bleichroeder units detached into shares and warrants; warrants converted to New Pasqal Warrants, and shares converted to New Pasqal Shares based on an exchange ratio referencing a deemed value of $10.00 per share. The original Registration Rights Agreement and Trust Agreement were terminated, replaced by an Amended and Restated Registration Rights Agreement and Lock-Up Agreements. All former directors and officers resigned effective upon the merger closing. Trading in BBCQ securities was suspended for delisting from Nasdaq, while New Pasqal Shares and Warrants are expected to trade under symbols PSQL and PSQLW. Why it matters: This filing confirms the completion of the deal, triggering the end of the SPAC's existence and the start of trading for the combined entity. It establishes the new capital structure, removes the trust account via termination of the investment management agreement, and outlines the post-closing governance through new registration rights and lock-ups. Investors should note the resignation of the entire prior management team and the specific exchange mechanics ($10.00 deemed value) used to convert their holdings.
What changed: Bleichroeder Acquisition Corp. II filed a Form 8-K under Rule 425 reporting the results of an Extraordinary General Meeting held on August 25, 2026, regarding its proposed business combination with Pasqal Holding SAS. The filing states that shareholders approved the Business Combination, Reincorporation Merger, French Merger, Governing Documents, Advisory Governing Documents, Director Elections for the New Pasqal Board, Incentive Plans (RSU, BSPCE, Stock Option, and Warrant Delegation), and Share Issuance proposals. Specifically, 21,467,865 shares voted FOR the Business Combination against 2,616,196 AGAINST. The document further reports that public shareholders holding 26,039,602 Class A ordinary shares validly elected to redeem their shares upon consummation. Why it matters: This filing confirms the shareholder approval required to proceed with the merger between Bleichroeder and Pasqal, validating the deal's governance structure and board composition. Crucially, it quantifies the redemption pressure: with 26,039,602 shares redeemed out of 28,750,000 public Class A shares outstanding, approximately 90.6% of public shares are being returned for cash. This massive redemption rate significantly reduces the trust value remaining in the SPAC, potentially impacting the cash available for the combined company's operations or requiring additional financing from sponsors or PIPE investors to meet post-merger liquidity needs.
What changed: Bleichroeder Acquisition Corp. II filed a Form 8-K reporting the results of an Extraordinary General Meeting held on August 25, 2026, where shareholders approved the business combination with Pasqal Holding SAS and related proposals. The filing discloses that 21,467,865 shares voted FOR the Business Combination Proposal against 2,616,196 AGAINST, constituting approval. It also reports that public shareholders holding 26,039,602 Class A ordinary shares validly elected to redeem their shares upon consummation of the closing. Why it matters: The shareholder vote confirms the necessary corporate governance approvals for the merger, while the redemption figure of 26,039,602 shares indicates the amount of trust value likely leaving the company, which directly impacts the post-merger cash position and dilution for remaining holders.
What changed: Form 8-K current report containing an amended and restated advisory services agreement. Per the filed agreement dated August 19, 2026, Bleichroeder Acquisition Corp. II updated its engagement with MJP Advisory Group LLC, an affiliate of Chief Executive Officer and Chief Operating Officer Marcello Padula. The updated contract replaces a November 24, 2025 arrangement and formally compensates extraordinary services delivered through February 28, 2026 regarding the proposed Pasqal Business Combination with Pasqal Holding SAS. The agreement mandates a monthly service fee of $18,000, a $1,850,000 payment triggered at the closing of the initial business combination, and a $600,000 payment triggered if the company liquidates. The registrant's filing expressly prohibits any of these fees from being paid from amounts held in the public shareholders’ trust account, specifying that closing proceeds or other corporate funds must cover them instead. It also confirms Mr. Padula has no guaranteed future position in the combined company absent a separately signed written statement from the board chair. Why it matters: This exhibit clarifies the mechanical and financial backdrop for the announced Pasqal Holding SAS merger ahead of the January 9, 2028 deadline. By isolating advisor compensation away from the trust account—valued at $10.17 per share—the filing assures investors that sponsor-linked payouts will not erode redemption values. Conversely, the structure reveals significant contingent liabilities: failure to close due to company termination without cause accelerates six additional months of monthly fees alongside the full $1,850,000 or $600,000 waterfall, demonstrating rigid financial incentives tied to deal execution. Furthermore, the document details clauses assigning all intellectual property created during the search to the company and enforcing strict confidentiality, underscoring standard shell-company transition protocols. Tracking the deal calendar, the explicit reference to a Merger Agreement executed on February 28, 2026 signals that substantive negotiations preceded this administrative compensation adjustment, providing concrete validation of merger progress for shareholders evaluating their redemption rights.
What changed: A Rule 425 written communication filed as a Current Report on Form 8-K, enclosing Exhibit 99.1, a joint press release dated August 20, 2026. The filing confirms proximate voting mechanics and calendar milestones without amending the merger agreement or extending the liquidation deadline. The SEC declared the joint Registration Statement on Form F-4 effective on August 5, 2026. Proxy materials were mailed to shareholders as of August 4, 2026, establishing a shareholder record date of August 5, 2026. An extraordinary general meeting to approve the business combination is scheduled for August 25, 2026. The document explicitly flags that the volume of redemption requests could leave the combined company with insufficient cash to execute its business plans. Why it matters: SPAC investors face a compressed decision window between material receipt and the August 25 vote, directly impacting redemption behavior and post-deal liquidity. The jointly issued press release attributes to management that Pasqal leverages Nobel Prize-winning research to build neutral-atom quantum computing systems and cloud-ready software targeting optimization, simulation, and artificial intelligence. The companies state Pasqal employs approximately 300 people in France and serves over 25 clients and partners, listing Saudi Aramco, LG Electronics, Crédit Agricole CIB, CMA CGM, OVHcloud, Thales, IBM, and Sumitomo. The filing discloses Pasqal has secured more than USD 300 million in total funding from leading international investors and aims to list on Nasdaq through this transaction. Cautionary statements warn Pasqal confronts risks related to commercializing emerging quantum technology, dependence on senior management, potential needs for additional future financing, and heavy concentration of revenue in government or state-funded contracts.
Show the other 10 filings
What changed: A Current Report on Form 8-K furnishing a joint press release reminding shareholders of an upcoming extraordinary general meeting to vote on the proposed business combination with Pasqal Holding SAS. The filing confirms that Bleichroeder Acquisition Corp. II’s joint registration statement on Form F-4 was declared effective by the SEC on August 5, 2026, and that definitive proxy materials were mailed to shareholders of record as of the close of business on August 5, 2026. An extraordinary general meeting is scheduled for August 25, 2026, to vote on the merger and related matters. This advances the transaction to its final shareholder approval stage, triggering the active period for potential redemption elections before the September 10 closing window typically follows such meetings. Why it matters: Investors weighing redemption decisions must evaluate the target alongside the extensive forward-looking risk disclosures attached to the proxy. According to the joint press release and accompanying prospectus, Pasqal is a France-based neutral-atom quantum computing firm founded in 2019 that employs approximately 300 people and serves over 25 clients and partners, including Saudi Aramco, LG Electronics, Crédit Agricole CIB, CMA CGM, OVHcloud, Thales, IBM, and Sumitomo. The company leverages Nobel Prize-winning research to build high-performance quantum systems and cloud-ready software for optimization, simulation, and artificial intelligence, and has been backed by more than USD 300 million in total funding from leading international investors. Management and the target explicitly flag risks inherent to the venture, citing potential technical challenges, delayed commercialization or market acceptance for the emerging technology, reliance on strategic partners and third parties, concentration of revenue in contracts with government or state-funded entities, and a potential need for additional future financing prior to or after the Business Combination.
What changed: A DEFA14A (Definitive Additional Materials) filing serving as Supplement No. 1 to a prior proxy statement/prospectus, which attaches the complete English and French text of the Cayman Islands and French Reincorporation Plan of Merger and corrects clerical errors in the articles of association of the surviving entity, explicitly stating that no changes are being made to the underlying business combination terms. Nothing materially altered the redemption calendar, trust mechanics, or extension provisions. The filing merely supersedes two annexes originally filed on August 5, 2026. Annex B provides the verbatim statutory plan governing how Bleichroeder Acquisition Corp. II merges into Bleichroeder Acquisition France Merger Sub 2, setting an effective date of 27 August 2026. Section G of the attached draft Merger and Absorption Agreement explicitly notes that the total number of shares 'may be reduced as a result of the exercise by the public shareholders... of their right to redeem their shares for a pro rata portion of the trust account,' and that the exchange ratio 'might be adjusted to reflect the actual number of the Absorbing Company shares outstanding at Completion Date.' It further states the contributed asset value 'may be adjusted to reflect any cash repayments made.' Why it matters: While procedurally supplemental, the document locks the exact balance sheet mechanics that will determine post-redeption share allocation and liquidation values. The Reference Accounts of the Absorbed Company list Investments held in Trust Account at 289,715,723 USD alongside accrued offering costs of 75,000, accrued expenses of 4,421,580, long-term prepaid insurance of 114,375, total current assets of 1,566,004, total current liabilities of 4,496,580, and a Deferred underwriting fee of 12,250,000, producing net assets contributed at 274,649,522 USD. The transaction relies on a stated exchange rate of 1 EUR = 1.16598 USD as of 31 May 2026 to convert these figures into 235,552,515.48 EUR. To fund the creation of 38,333,333 new shares at a par value of approximately 6.14 EUR each, the absorbing company raises capital by 235,549,545.29 EUR while simultaneously reducing it by 50,000 EUR through cancellation of 8,137 self-held shares, booking a merger premium of 2,970.19 EUR. The preamble frames the restructuring as achieving 'market expansion and access to new clients,' securing 'access to U.S. capital markets' for 'facilitated access to institutional and retail investors,' and providing 'enhanced international credibility.' Post-merger governance will be overseen by a board comprising Dr. Wasiq Bokhari, Alain Aspect, Georges-Olivier Reymond, Michel Combes, Barbara Dalibard, Michael Blitzer, Nicolas Berdou, Jean Ruby, and Andrew Gundlach. Shareholder approvals remain due no later than 30 September 2026, with automatic termination if uncompleted by 31 October 2026.
What changed: Proxy Statement/Prospectus Supplement No. 1 (Form 425) filed by Bleichroeder Acquisition Corp. II to update Annex B (Reincorporation Plan of Merger, including both Cayman and French merger plans) and Annex H-1 (corrected articles of association of New Pasqal) to the definitive proxy statement/prospectus dated August 5, 2026, for the business combination with Pasqal. No changes are made to the underlying Proxy Statement/Prospectus terms; the supplement only replaces the referenced annexes with full-text versions and corrects clerical errors in the New Pasqal articles. The filing states: (A) Annex B is updated to include the full text of the Cayman Reincorporation Plan of Merger (plan of merger under Part 16 of Cayman Companies Act) and the French Reincorporation Plan of Merger (traité de fusion under French Commercial Code) for the reincorporation merger of Bleichroeder Acquisition Corp. II into the French sub, Bleichroeder Acquisition France Merger Sub 2; (B) Annex H-1 is updated to correct clerical errors in the amended and restated articles of association of New Pasqal. The exchange ratio remains 1:1. The merger effective date is stated as 27 August 2026. The Merger Sub's share capital will be EUR 50,000 (8,137 shares) before the merger and EUR 235,549,545.29 (38,333,333 shares) after. The net assets contributed by the Absorbed Company (Bleichroeder) are stated as USD 274,649,522. The trust account balance is stated as USD 289,715,723 as of 31 March 2026. Public shareholders' redemption right is disclosed: share count and contributed asset value may be reduced by redemptions, with a possible exchange ratio adjustment. The merger plan may lapse automatically if not completed by 31 October 2026. Why it matters: For investors tracking this deal, this supplement provides the final legal merger documents for the reincorporation step, confirming the 1:1 share exchange and the key deadline (effective date 27 August 2026, with automatic lapse on 31 October 2026). The trust account is disclosed at $289.7M. Redemption risk remains live, and any redemptions will reduce the post-merger cash available to the combined company. The corrected articles of association for the ultimate surviving company (Pasqal Holding) are now on the record. No new financial projections or business updates on Pasqal are provided.
What changed: A Schedule 13G beneficial ownership report identifying three associated reporting parties: Fort Baker Capital Management LP, Steven Patrick Pigott, and Fort Baker Capital, LLC. The excerpt contains no updates on redemption deadlines, trust account balances, extension mechanisms, target business development, or sponsor conduct. It lists entity names but omits all percentage thresholds, share quantities, acquisition costs, and effective dates required to assess beneficial ownership changes or control shifts. Why it matters: This filing functions as a routine registration of holding status rather than a disclosure of transactional activity or strategic direction. Because the text provides no numerical holdings, voting agreements, or board nominations, it does not alter the SPAC’s structural timeline or capitalization mechanics. Investors monitoring the redemption window and trustee distributions should treat this as a baseline compliance marker; substantive signals regarding liquidity events, sponsor leverage, or merger momentum will require subsequent 13D/G amendments that quantify stakes or declare intent.
What changed: This document IS a Proxy Statement/Prospectus Supplement No. 1 that files an updated Annex B containing the full text of the Cayman Islands and French Reincorporation Plan of Merger, while simultaneously correcting clerical errors in Annex H-1 regarding the amended and restated articles of association of New Pasqal. According to Section G of the attached Merger Agreement, public shareholders retain a redemption right to exchange shares for a pro rata portion of the trust account; the document states that redeeming shares may reduce the total share count, potentially adjusting the exchange ratio to reflect actual shares outstanding at completion, with contributed asset value further adjusted for any cash repayments. The Plan of Merger sets the Effective Date as 27 August 2026, requires extraordinary general meeting approvals no later than 30 September 2026, and stipulates automatic lapse without indemnity if uncompleted by 31 October 2026. Per the Reference Accounts of the Absorbed Company as of 31 March 2026, Assets Contributed total USD 291,396,102 (Cash USD 1,331,014; Prepaid expenses USD 234,990; Long-term prepaid insurance USD 114,375; Investments held in Trust Account USD 289,715,723), offset by Liabilities Assumed of USD 16,746,580 (Accrued offering costs USD 75,000; Accrued expenses USD 4,421,580; Deferred underwriting fee USD 12,250,000), establishing Net Assets of USD 274,649,522. The parties fix a one-to-one exchange ratio, executing a capital increase of EUR 235,549,545.29 through 38,333,333 new shares at approximately EUR 6.14 par value, alongside a capital reduction of EUR 50,000 canceling 8,137 self-owned shares. According to Schedule 10 of the Plan, pre-merger surviving directors are Michel Combes, Marcello Padula, and Andrew Gundlach, with the post-merger board expanding to include Dr. Wasiq Bokhari, Alain Aspect, Georges-Olivier Reymond, Barbara Dalibard, Michael Blitzer, Nicolas Berdou, and Jean Ruby. Under Section 1.4 of the Merger Agreement, off-balance-sheet commitments are disclosed as None, and Section 3.2 specifies that Bleichroeder Acquisition Corp. II currently employs zero staff. Why it matters: According to the Supplement, the explicit linkage between redemption exercises, share count adjustments, and contributed asset valuation means actual trust distributions will mechanically scale post-combination ownership and net asset backing per share. The hard calendar deadlines eliminate indefinite extension ambiguity and force accelerated execution before the 31 October 2026 cutoff. The fixed one-to-one parity, combined with the accounting rule that contributions transfer at book value rather than fair market value under French General Chart of Accounts regulations, dictates how historical SPAC liquidity converts into the surviving entity’s equity base. As outlined in Section D of the Merger Agreement, the transaction targets market expansion, access to U.S. capital markets for institutional and retail investors, enhanced international credibility, and capital structure optimization to issue new financial instruments and employee incentive mechanisms. Under Article 3 of the New Pasqal Articles of Association, the surviving company’s corporate purpose centers on quantum computing, quantum simulation, neutral atom laser technologies, software/hardware development, IP exploitation, and consulting services. The appointed nine-member leadership and specified corporate governance rules in Articles 13 through 25 establish the operational and fiduciary framework for the listed European entity.
What changed: Schedule 13G/A amendment, a routine SEC beneficial ownership disclosure. The filing identifies Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh as reporting entities. The excerpt provides no amended share counts, percentage thresholds, transaction dates, or statements of investment purpose. Consequently, there is no disclosed alteration to the mechanics governing shareholders: the $10.17 per-share trust balance, the 2028-01-09 business combination deadline, any extension provisions, or sponsor conduct remain unaffected by the visible text. Why it matters: As a routine compliance exhibit tracking institutional position adjustments, this 13G/A signals that the named holders have updated a prior disclosure, potentially reflecting portfolio rebalancing or regulatory recalibration. Without the numerical amendments or purpose clauses, it offers no actionable data on redemption pressure, merger approval probability, or capital allocation strategy. Investors should consult the complete exhibit to determine whether the filing records an increase, decrease, or mere clarification of holdings, as only those figures would impact valuation modeling or deal timeline assessments.
What changed: A Schedule 13G beneficial ownership report filed on 2026-08-14 under identification number 0000919574-26-005329, submitted by Highbridge Capital Management, LLC to declare share holdings in Bleichroeder Acquisition II (BBCQ). The filing registers a regulatory statement of beneficial ownership by Highbridge Capital Management, LLC. It contains no amendments to corporate action timelines, no recalculation of trust balances, no extension proposals, no updates to merger execution status, and no descriptions of sponsor conduct. Why it matters: Investors monitoring redemption windows, trust preservation, extension mechanisms, deal progress, or sponsor behavior will note that this routine 13G submission functions exclusively as an ownership registry. The document makes no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, and provides no operational or structural signals beyond the act of institutional share disclosure.
What changed: A Schedule 13G/A amendment reporting aggregated beneficial ownership of BBCQ securities across affiliated Continental Insurance entities and Michael Gorzynski. The filing consolidates reporting across CONTINENTAL GENERAL INSURANCE CO, Continental Insurance Group, Ltd., Continental General Holdings LLC, and Gorzynski Michael as related beneficial owners. It contains no updates to redemption mechanics, trust valuations, extension votes, merger timelines, or sponsor conduct. Why it matters: For shareholders tracking liquidity windows and deal momentum, this amendment reflects administrative alignment of affiliate disclosures rather than a shift in blockholder voting weight or redemption intent. Because the excerpt provides neither aggregate share quantities nor investment purposes, it offers no indication of whether the Continental group intends to convert shares, vote for the proposed business combination, or exercise withdrawal rights ahead of the expiration date. The filing does not trigger new shareholder remedies, alter trust distribution schedules, or signal changes in management oversight or sponsorship agreements.
What changed: Quarterly report (Form 10-Q) for the period ended June 30, 2026. The trust value increased from $287.5 million at IPO to $292,280,120 as of June 30, 2026, reflecting $4.78 million of interest earned year-to-date. The redemption value per share rose from $10.00 to $10.17. Working capital was $866,407, with a deficit of $5,158,160. The company reported a net loss of $2.39 million for the six months. Three amendments were made to the Business Combination Agreement (Amendments No. 1, No. 2, and No. 3) and the SPA was amended to increase a private investment by $50.0 million to $250 million aggregate purchase price. The outside date to close the Pasqal deal automatically extends to December 31, 2027 unless both parties terminate earlier. The company also noted a going concern qualification due to liquidity constraints. Why it matters: This filing provides the first detailed look at trust mechanics and deal economics for BBCQ since its IPO. Key for investors: (1) the trust is accumulating interest and the redemption value is already $10.17, (2) the Pasqal deal has a minimum cash condition of $150 million available at closing, (3) a $250 million convertible note PIPE (20% OID) is contingent on closing, and (4) there is a clear path to a year-end 2026 termination/long-stop with an automatic extension to 2027. The sponsor conduct: sponsor received 9.58 million founder shares for $25,000 (approx. $0.003/share) and agreed to not redeem in favor of the deal. The independent directors/COO/CFO received stock grants contingent on deal close. The company has substantial doubt about going concern absent a deal.
What changed vs 2026-05-07trust $289.7M → $292.3M +1%trust account, combination deadline, going-concern doubt +11 moved · 3 with no prior record of ours
- Trust account
- $289.7M$292.3M
- Combination deadline
- 2026-12-31 · unchanged
- Going-concern doubt
- stated · unchanged
- Redeemable shares
- 28.8M · unchanged
SpacBrain reads this as $2,564,397 was added to the trust between the two filings.
The clause …“offering costs — 217,025 Long-term prepaid insurance 76,250 — Investments held in Trust Account 292,280,120 — Total Assets $ 293,427,190 $ 221,528 Liabilities and Shareholders’ Deficit Current Liabilities Accrued offering costs $”…
The clause …“to the other or otherwise mutually agree in writing to terminate the Business Combination Agreement at least ten business days prior to December 31, 2026, and (B) for an additional 60 days if (1) the Registration”…
The clause …“acceptable terms, if at all. The Company’s liquidity condition raises substantial doubt about the Company’s ability to continue as a going concern. Management plans to address this uncertainty through a Business Combination.”…
The clause …“none issued and outstanding at June 30, 2026 and December 31, 2025 (excluding 28,750,000 shares subject to possible redemption) — — Class B ordinary shares, $ 0.0001 par value; 50,000,000 shares authorized; 9,583,333 shares issued and”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: SEC Schedule 13G/A, a passive beneficial ownership amendment reporting updated shareholder positions. The amended report lists three reporting persons—Adage Capital Management, L.P., Robert Atchinson, and Phillip Gross. The supplied excerpt contains no share quantities, percentage of outstanding common stock, acquisition or disposition dates, or purpose-of-transaction language. Why it matters: For a SPAC in DEAL_ANNOUNCED status, a 13G/A updates the public ledger of passive institutional holdings but does not alter the January 9, 2028 redemption deadline, the stated $10.17 per-share trust balance, or merger execution timelines. Because the excerpt omits quantum and percentage data, it does not mechanically trigger redemption windows, indicate sponsor lock-up activations, or reveal new customer, revenue, market-size, technology, or partnership claims. It functions solely as a periodic Section 13(d) compliance update reflecting aggregate ownership that sits at or near the 5% reporting threshold.
The sponsor
The people who set this company up, what they have done before, and the advisers around the deal.
Liquidation / termination drag: 0 liquidations and 0 terminations across 14 vehicles raised → 0% attrition (terminations 1.25×, stale shells 0.75×).
Mixed record · high confidence
- Bleichroeder Acquisition Corp I · 2024→ Merlin IncMRLNCompleted
Bleichroeder — RIA-affiliated SPAC line tied to Michael Blitzer's Inflection Point. Prior-vehicle track record (SEC-verified via formerNames): Bleichroeder Acquisition Corp I (formerly Inflection Point Acquisition Corp IV) COMPLETED → Merlin Inc (MRLN, Nasdaq, 2026). Current vehicles BBCQ (in-deal) and BCCQ (searching). Net: 1 completed deSPAC (still listed). Sources: SEC EDGAR submissions API (formerNames) + full-text search, efts.sec.gov. — research profile — Bleichroeder is a New York-based registered investment advisor focused on ultra-high-net-worth families, with roots tracing back to the storied Arnhold and S. Bleichroeder investment bank originally founded in Germany in 1931 and relocated to New York in 1937. That firm's asset management arm was eventually renamed First Eagle Investment Management, with majority control sold to Blackstone and Corsair Capital in December 2015. The Bleichroeder name persists in the SPAC franchise, which is led by Andrew Gundlach, the co-CEO of Bleichroeder and head of Goldiron, who serves as Executive Chairman across the vehicles. Gundlach co-founded the first two SPACs alongside Michel Combes, the well-known telecom and technology executive. The management bench also includes Marcello Padula as CEO of the second and third vehicles (a former BofA Securities investment banking VP who executed over $25 billion in transactions), Robert Folino as CFO (also COO and Head of Trading at Bleichroeder), and directors including Christopher Kellen of First Eagle Administrative Services, Clemence Rasigni (a former Senior Managing Director at Merrill Lynch with over two decades of capital markets experience), Kathy Savitt, Antoine Theysset, and Philippe Nyssen. Bleichroeder Acquisition Corp. I (BACQ) raised $250 million in October 2024 and was reportedly trading approximately 14% above its $10 offer price; it is pending a combination with Merlin, an autonomous aircraft pilot technology developer, and has since been renamed Inflection Point Acquisition Corp. IV. Bleichroeder Acquisition Corp. II (BBCQ) priced a $250 million IPO in January 2026 (closing at $287.5 million with overallotment), and on March 4, 2026 announced a definitive business combination with Pasqal, a French neutral-atom quantum computing company, at a $2.0 billion pre-money valuation with a deal size of approximately $2.64 billion. The transaction includes $250 million in committed convertible financing (upsized from an initial $200 million) backed by sponsor-affiliated investor Inflection Point, BPIfrance Large Venture, and other institutional investors, targeting up to $500 million in gross proceeds for Pasqal assuming no redemptions. The SEC declared the joint F-4 registration statement effective on August 5, 2026, with a shareholder vote scheduled for August 25, 2026. BBCQ shares have traded modestly above trust value at around $10.18 to $10.20. Bleichroeder Acquisition Corp. III (BCCQ) priced a $300 million IPO on July 7, 2026, backed by Bleichroeder Sponsor 3 LLC, and has not yet identified a target; it focuses on disruptive growth industries with a global mandate. The BBCQ-Pasqal deal is the sponsor's most significant pending transaction and carries both notable ambition and potential concerns. Pasqal, co-founded by Nobel laureate Alain Aspect, has deployed seven quantum computers and serves over 25 commercial customers including Sumitomo, CMA CGM, and Thales, with partnerships spanning IBM and NVIDIA. However, the company reported only approximately €16 million in 2025 commercial revenue against a €66 million-plus booked and awarded business pipeline, making the $2 billion pre-money valuation a rich
1 sentence withheld from the text above. It stated a vehicle count (three vehicles) that does not reconcile with the record we counted: 14 vehicles — 13 in the live database and 1 SEC-verified prior vehicles. Neither side has been corrected here, and the stored research is unchanged; a count we cannot reconcile is not a count we will publish.
Full sponsor record →Deal team — named in the prospectus
- Cohen & Company Capital MarketsLead-left
- Clear Street LLCBook-runner
Read from this SPAC’s own prospectus; the arrow opens the filing. Firms link to their full mandate record.
The record
The reference detail — how the shares were structured at listing, how thinly they trade, and where the company is registered.
Show the reference detail
Unit structure
That was the figure at listing. It is $10.17 a share today — interest on the account, plus any sponsor payments made to extend the deadline, spread over the shares that never cashed out.
from 424B3 0001213900-26-085694
as of 28 August 2026
Trading & liquidity
Company profile
DEAL: Pasqal — vote Aug 25
Directors & officers
- Gundlach AndrewChief Executive Officer
- Combes Michel10% owner
- Padula Marcello J.Chief Operating Officer
- Folino RobertChief Financial Officer
- Rasigni ClemenceDirector
- Nyssen Philippe Claude ThomasDirector
- Savitt Katherine JDirector
- Theysset AntoineDirector
Institutional holders
from SC 13G/13DFunds that have declared a stake above 5%. Heavy ownership by arbitrage funds usually means heavy cash-outs at the next vote.
Show the declared stakes
10 filers with a stake on file · 10 re-affirmed in the last 12 months. A stake with no amendment since is the filer’s last word on it, not proof it is still held — and percentages filed in different years are percentages of different floats, because this vehicle’s share count collapses at every redemption.
- Fort Baker Capital Management LP7.2% · SC 13GAug 14, 2026 fresh
- Alyeska Investment Group, L.P.7.0% · SC 13G/AAug 14, 2026 fresh
- HIGHBRIDGE CAPITAL MANAGEMENT LLC5.7% · SC 13GAug 14, 2026 fresh
- LMR Partners LLP5.6% · SC 13GMay 15, 2026 fresh
- MERUS GLOBAL INVESTMENTS, LLC5.3% · SC 13GJun 5, 2026 fresh
- Linden Capital L.P.5.2% · SC 13GJan 13, 2026 fresh
- Adage Capital Management, L.P.3.7% · SC 13G/AAug 12, 2026 fresh
- MILLENNIUM MANAGEMENT LLC2.8% · SC 13G/AJul 15, 2026 fresh
- CONTINENTAL GENERAL INSURANCE COnot stated · SC 13G/AAug 13, 2026 fresh
- BLEICHROEDER SPONSOR 2 LLCnot stated · SC 13GApr 13, 2026 fresh
One line per filer, not per reporting person: a joint schedule names the management company, its funds and often the individual who controls them, and all of them report the same shares. Click a name for that filer’s whole footprint across every SPAC it has declared a stake in.
Sources on file
harvested pages, kept in fullEvery public page we have read about this company, stored in full so a source can never go missing.
Show the sources
37 full SEC filing texts archived — searchable, never lost.
- Vault note — BBCQ (Bleichroeder Acquisition II)
vault-note · /vault/tickers/BBCQ
- Vault deal note — Pasqal (BBCQ)
vault-note · /vault/deals/pasqal
- bspac2.com
company-site · bspac2.com
Cash in trust over time
XBRL, per filingHow much cash has stood behind each share at each filing date.
Show the filed values
- 30 June 2026—
- 30 June 2026$10.17
- 31 March 2026—
In plain English
tap a term to open itEvery piece of jargon this page could have used, and what it actually means.
Open the plain-English guide
No floor / floorlessthe cash guarantee is gone — the price is unprotected
A SPAC's downside protection is not the cash in trust; it is your right to demand that cash. Once the redemption window closes, the cash stays with the company and the share can trade anywhere.
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Broker action datethe day your broker needs the instruction — earlier than the official date
Brokers batch redemption instructions to the transfer agent, so the practical cutoff is roughly two business days before the published deadline. This is the date that actually costs people the floor.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Trust discountbuying below the cash held for you
Only meaningful while a redemption right exists. On a floorless name the same arithmetic is not a discount, it is the market pricing distress, and this product will not call it a yield.
Dilutionhow much of the company new shares take from you
Sponsor promote, PIPE shares, warrants and rights all issue stock that did not pay $10 for it. The headline deal value is before that; the effective value is after.
Pro-forma equitywhat the company is valued at once the deal closes
The combined company's equity value assuming the announced terms and the redemptions that have actually happened.
ARShow much upside you get per unit of downside
SpacBrain's asymmetric-return score. It is deterministic — the same inputs always produce the same number — and it is capped, not zeroed, when the floor is gone.
De-SPACthe day the SPAC becomes the real company
The shares stop being a claim on a pot of cash and start being equity in an operating business. Roughly 80% of recent de-SPACs traded below $10 within a year.
Outside datethe contractual long-stop for closing the deal
A deadline between the SPAC and its target, not between the SPAC and you. It confers no right to cash, which is exactly why it must never be counted as a redemption window.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.
Accreted NAV (estimate)the last filed cash figure, plus the interest it should have earned since
A model, not a filing: last filed value compounded at the 3-month T-bill for the days elapsed. Always shown in italic with the word estimate, and never printed beside a filed number without it.
Ask the brain
from its filingsData provenance & audit trail15 internal entries
Written by SpacBrain’s data agents whenever a figure is captured, corrected or flagged, and kept verbatim so every number on this page can be traced back to the filing that states it. This is a running log, not the current record: an early entry may be superseded by a later correction — the panels above always hold the current values.
Charter deadline 2028-01-09 (24mo from IPO) per DEFM14A 0001213900-26-085816 (filed).
ipoSizeM 250->287.5: 28,750,000 units incl. 3,750,000 over-allotment units (full exercise) (acc 0001213900-26-002963)
trust/share $10.17 from 10-Q acc 0001213900-26-089101 as of 2026-06-30
warrantStrike=11.5, warrantCallPrice=18, unitSeparationDays=52 from the definitive prospectus (0001213900-26-002472). NOT FILLED: rightShareRatio — no stated candidate · [LIFECYCLE 2026-08-27 · 0001213900-26-094397] CLOSED per 8-K (effective 2026-08-27) — "On August 27, 2026 (the “ Closing Date ”), Bleichroeder Acquisition Corp. II, a Cayman Islands exempted company (“ Bleichroeder ” or “ Parent ”), consummated the previously announced business combination pursuant to the Agreement and Plan o" — de-SPAC complete
announcedAt=2026-02-28 from Agreement and Plan of Merger with Pasqal Holding SAS (8-K Item 1.01, signing date 2026-02-28, acc 0001213900-26-023839).
Vote 2026-08-25; redemption DL 2026-08-21; outside date 2026-12-31 (auto-ext 2027-12-31). DEFM14A 0001213900-26-085816.
Primary-source deal structure (0001213900-26-023839, 0001213900-26-084072, 0001213900-26-023841). effective equity $2644M vs headline $2000M (+32.2%) [pro-forma-stated, high]: public-shares=264.4M sh/$2644M | F-4/A on file (acc 0001213900-26-084072) but no single stated pro-forma total share count captured | pipeSizeM uses the $200 million aggregate cash purchase price; the instruments have a $250 million aggregate principal amount (20% original issue discount), both stated in the same sentence | financing is senior unsecured convertible bonds plus warrants, not a common-stock PIPE at a fixed $10.00 price | no earnout disclosed in the BCA 8-K or the F-4/A | termination fee is payable by Legacy Pasqal to Bleichroeder (reverse direction from the usual SPAC target-side fee) | F-4/A pro forma ownership table shows 75.7% Legacy Pasqal / 10.9% public / 3.6% Sponsor / 9.9% Investors assuming no redemptions, which is a fully diluted-style presentation that differs from the 238,333,333 basic share table used for proFormaSharesM | F-4 not yet effective as of 2026-08-14 (latest is F-4/A filed 2026-07-31)
headline changed to $2000M after the original write; effective equity re-derived.
expected close as filed: "Vote 25 Aug 2026" — not a period the filing stated; stored NULL.
expected close as filed: "second half of 2026" — typed as H2 2026; the remainder is attribution, not a stated close.
QUANTUM confirmed, on 8-K 0001213900-26-094397: "Pasqal (Nasdaq: PSQL) helps organizations tackle problems that are difficult or impossible to solve with conventional computing methods alone." · [LIFECYCLE 2026-08-27 · 0001213900-26-094397] CLOSED per 8-K (effective 2026-08-27) — "On August 27, 2026 (the “ Closing Date ”), Bleichroeder Acquisition Corp. II, a Cayman Islands exempted company (“ Bleichroeder ” or “ Parent ”), consummated the previously announced business combination pursuant to the Agreement and Plan o"
pipeBasis set to UNSOURCED: the size came from the research seed / an earlier record and no filing we hold states it — surfaces now label it "unsourced"; an LLM re-read to FILED replaces this when credits allow
5:00pm ET, 2 business days before 8/25 EGM. Est. ~$10.00/sh (proxy illustrative, trust as of 2026-04-30).
EGM 10:00am ET 2026-08-25 (webcast). Quantum (Pasqal). From DEFM14A.
Auto-extends to 2027-12-31 absent mutual termination notice 10 BD prior.